Online supplemental material
暂无分享,去创建一个
P. Kemmeren | P. Lijnzaad | H. van Bakel | P. Roepman | G. Hordijk | N. Kettelarij | D. van Leenen | M. Radonjic | A. Miles | M. Tilanus | R. Koole | G. Daley | L. Wessels | P. C. Van | De Peppel
[1] T. Phan,et al. Altered Migration, Recruitment, and Somatic Hypermutation in the Early Response of Marginal Zone B Cells to T Cell-Dependent Antigen1 , 2005, The Journal of Immunology.
[2] Philip Lijnzaad,et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas , 2005, Nature Genetics.
[3] Gordon K. Smyth,et al. limmaGUI: A graphical user interface for linear modeling of microarray data , 2004, Bioinform..
[4] B. Clurman,et al. Notch Activation Induces Endothelial Cell Cycle Arrest and Participates in Contact Inhibition: Role of p21Cip1 Repression , 2004, Molecular and Cellular Biology.
[5] A. Karsan,et al. Notch4-induced inhibition of endothelial sprouting requires the ankyrin repeats and involves signaling through RBP-Jkappa. , 2004, Blood.
[6] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[7] R. Willemze,et al. Aberrant Expression of the Tyrosine Kinase Receptor EphA4 and the Transcription Factor Twist in Sézary Syndrome Identified by Gene Expression Analysis , 2004, Cancer Research.
[8] Zhijin Wu,et al. Preprocessing of oligonucleotide array data , 2004, Nature Biotechnology.
[9] Linheng Li,et al. Notch Activation Results in Phenotypic and Functional Changes Consistent With Endothelial-to-Mesenchymal Transformation , 2004, Circulation research.
[10] A. Karsan,et al. Notch4 Inhibits Endothelial Apoptosis via RBP-Jκ-dependent and -independent Pathways* , 2004, Journal of Biological Chemistry.
[11] Carlos S. Moreno,et al. MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast Cancer , 2003, Cell.
[12] P. Kemmeren,et al. Monitoring global messenger RNA changes in externally controlled microarray experiments , 2003, EMBO reports.
[13] G. Rubin,et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[14] Annick Harel-Bellan,et al. The Retinoblastoma Protein Binds the Promoter of the Survival Gene bcl-2 and Regulates Its Transcription in Epithelial Cells through Transcription Factor AP-2 , 2002, Molecular and Cellular Biology.
[15] A. Ström,et al. The Anti-estrogenic Effect of All-trans-retinoic Acid on the Breast Cancer Cell Line MCF-7 Is Dependent on HES-1 Expression* , 2002, The Journal of Biological Chemistry.
[16] A. Namane,et al. Protein sequencing and identification using tandem mass spectrometry. Edited by Michael Kinter, Nicholas E. Sherman, published by Wiley-Interscience Series on Mass Spectrometry, 2000, 301 p. , 2002 .
[17] H. Koeppen,et al. Dynamics of notch expression during murine prostate development and tumorigenesis. , 2001, Cancer research.
[18] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] Shiuan Chen,et al. Down-regulation of promoter 1.3 activity of the human aromatase gene in breast tissue by zinc-finger protein, snail (SnaH). , 2001, Cancer research.
[20] J. Herman,et al. Methylation Patterns of the E-cadherin 5′ CpG Island Are Unstable and Reflect the Dynamic, Heterogeneous Loss of E-cadherin Expression during Metastatic Progression* , 2000, The Journal of Biological Chemistry.
[21] M. Zeng,et al. Hemoglobin induction in mouse macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] K. Rajewsky,et al. Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification. , 1997, Immunity.
[23] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[24] R. Naviaux,et al. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses , 1996, Journal of virology.
[25] C. Bona,et al. Germline V genes encode viable motheaten mouse autoantibodies against thymocytes and red blood cells. , 1990, Journal of immunology.
[26] S. Tonegawa,et al. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene , 1983, Cell.
[27] J. Banerji,et al. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes , 1983, Cell.
[28] G E Wu,et al. Nucleotide sequence of a chromosomal rearranged lambda 2 immunoglobulin gene of mouse , 1982, Nucleic Acids Res..
[29] S. Pillai,et al. Marginal zone B cells. , 2005, Annual review of immunology.
[30] B. Haines,et al. Germline diversity of the expressed BALB/c VhJ558 gene family. , 2001, Molecular immunology.
[31] B. Bogen,et al. A rearranged lambda 2 light gene chain retards but does not exclude kappa and lambda 1 expression. , 1991, European journal of immunology.